DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Ramalingam SS, Mazières J, Planchard D et al.
Phase II Study of Nivolumab (anti-PD-1) in Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer.
2014 Chicago Multidisciplinary Symposium on Thoracic Oncology 2014 abstr 3462
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.